There are a variety of primary gain-of-function mutations in the receptor tyrosine kinases (RTKs) KIT and PDGFRA that are the prime oncogenic drivers of GIST [1, 2]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.